3rd Quarter - Report

PODESTA GROUP, INC. for GENZYME

Firm
Client
Income
$130,000
Expenses
—

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Kennedy American Affordable Health Choices Act of 2009 H.R. 3200 American Affordable Health Choices Act of 2009 Tri Caucus Healthcare Reform Bill Baucus/Finance Healthcare Reform Bill - America's Healthy Future Act of 2009 S. 1110 Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009 H.R. 2502 Comparative Effectiveness Research Act of 2009 S. 1213 Patient-Centered Outcomes Research Act of 2009 S. 301 Physician Payments Sunshine Act of 2009

LobbyistCovered position, as disclosed
DANIELE BAIERLEIN —
TEAL BAKER Executive Assistant Rep. Brian Baird
PAUL BRATHWAITE Executive Director, Congressional Black Caucus
SHARON COHEN —
RANDALL GERARD —
TIMOTHY A GLASSCO New —
JAIME R HARRISON New Policy Advisor/Counsel, Rep. James Clyburn
ARANTHAN JONES Health Policy Dir., Congressional Black Caucus
ANDREW KAUDERS New Sr. Adv, Sen. Menendez; ED House Dem Caucus
ISRAEL S KLEIN New Press Secretary & Leg. Aide, Rep Ed Markey
ELIZABETH ANN MORRA 1995-2001 House Appropriations Committee
ANTHONY PODESTA —
WALTER PRYOR Staff, Senator David Pryor
OSCAR RAMIREZ New Legislative Director for Rep. Joe Baca
THOMAS B SPARKMAN New Health Policy Intern, Senate HELP Committee
DONNI TURNER Legislative Assistant, Sen. Richard Durbin
NICOLE C YOUNG —

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 301 (111th), H.R. 3200 (111th), S. 1213 (111th), S. 1110 (111th), H.R. 2502 (111th)

Medicare/Medicaid MMM

Medicare Issues S. 301 Physician Payments Sunshine Act of 2009 Kennedy American Affordable Health Choices Act of 2009 H.R. 3200 America's Affordable Health Choices Act of 2009 Tri Caucus Healthcare Reform Bill Baucus/Finance Healthcare Reform Bill - America's Healthy Future Act of 2009 S. 1110 Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009 H.R. 2502 Comparative Effectiveness Research Act of 2009 S. 1213 Patient-Centered Outcomes Research Act of 2009

LobbyistCovered position, as disclosed
DANIELE BAIERLEIN —
TEAL BAKER Executive Assistant, Rep. Brian Baird
PAUL BRATHWAITE Executive Director, Congressional Black Caucus
SHARON COHEN —
RANDALL GERARD —
TIMOTHY A GLASSCO New —
JAIME R HARRISON New Policy Advisor/Counsel, Rep. James Clyburn
ARANTHAN JONES Health Policy Dir., Congressional Black Caucus
ANDREW KAUDERS New Sr. Adv, Sen. Menendez; ED House Dem Caucus
ISRAEL S KLEIN New Press Secretary & Leg. Aide, Rep Ed Markey
ELIZABETH ANN MORRA House Appropriations Committee, 1995-2001
ANTHONY PODESTA —
WALTER PRYOR U.S. Senator David Pryor
OSCAR RAMIREZ New Legislative Director for Rep. Joe Baca
THOMAS B SPARKMAN Health Policy Intern, Senate HELP Committee
DONNI TURNER Legislative Assistant, Sen. Richard Durbin
NICOLE C YOUNG —

Contacted: SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2502 (111th), H.R. 3200 (111th), S. 1213 (111th), S. 1110 (111th), S. 301 (111th)

Budget/Appropriations BUD

H.R. 1 American Recovery and Reinvestment Act of 2009 S. Con. Res. 13 H. Con. Res. 85

LobbyistCovered position, as disclosed
SHARON COHEN —
ANDREW KAUDERS Executive Director, House Democratic Caucus
ELIZABETH ANN MORRA —
ANTHONY PODESTA —
THOMAS B SPARKMAN Health Policy Intern, Senate HELP Committee
NICOLE C YOUNG —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.Con.Res. 85 (111th), H.R. 1 (111th), S.Con.Res. 13 (111th)

Taxation/Internal Revenue Code TAX

H.R. 3156 Neglected Disease Tax Credit Bill

LobbyistCovered position, as disclosed
PAUL BRATHWAITE Executive Director, Congressional Black Caucus
SHARON COHEN —
DAVID MARIN Press Secretary, Rep. Tom Davis
THOMAS B SPARKMAN Health Policy Intern, Senate HELP Committee
MICHELLE TESSIER —
NICOLE C YOUNG —

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3156 (111th)

Copyright/Patent/Trademark CPT

S. 515 Patent Reform Act of 2009 S. 610 Patent Reform Act of 2009 H.R. 1260 Patent Reform Act of 2009

LobbyistCovered position, as disclosed
SHARON COHEN —
ANTHONY PODESTA —
THOMAS B SPARKMAN Health Policy Intern, Senate HELP Committee
NICOLE C YOUNG —

Contacted: Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: S. 610 (111th), S. 515 (111th), H.R. 1260 (111th)

Pharmacy PHA

H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 3156 Neglected Disease Tax Credit Bill

LobbyistCovered position, as disclosed
TEAL BAKER Executive Assistant Rep. Brian Baird
PAUL BRATHWAITE Executive Director, Congressional Black Caucus
SHARON COHEN —
ARANTHAN JONES Health Policy Director Congressional Black Caucus
ANTHONY PODESTA —
THOMAS B SPARKMAN Health Policy Intern, Senate HELP Committee
DONNI TURNER Legislative Assistant, Sen. Richard Durbin
NICOLE C YOUNG —

Contacted: Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1548 (111th), H.R. 1427 (111th), H.R. 3156 (111th), S. 726 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.